Anavex Life Sciences Corp.盘中异动股价大跌5.10%报10.75美元

市场透视2025-01-16

北京时间2025年01月16日22时53分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.10%。截至发稿，该股报10.75美元/股，成交量18.9571万股，换手率0.22%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-43.00百万美元，每股收益-0.52美元，毛利0.00美元，市盈率-20.72倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2503156539?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-16 22:53","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2503156539","market":"us","top_or_hot":-1,"title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元","media":"市场透视","content":"<div>\n<p>北京时间2025年01月16日22时53分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.10%。截至发稿，该股报10.75美元/股，成交量18.9571万股，换手率0.22%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-43.00百万美元，每股收益-0.52美元，毛利0.00美元，市盈率-20.72倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-16 22:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年01月16日22时53分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.10%。截至发稿，该股报10.75美元/股，成交量18.9571万股，换手率0.22%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-43.00百万美元，每股收益-0.52美元，毛利0.00美元，市盈率-20.72倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVXL","symbol_name":"Anavex Life Sciences Corp.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b","article_id":"2503156539","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2503156539","pubTimestamp":1737039224,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年01月16日22时53分，Anavex Life Sciences Corp.股票出现异动，股价大幅下跌5.10%。截至发稿，该股报10.75美元/股，成交量18.9571万股，换手率0.22%，振幅5.83%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.76%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AVXL":"Anavex Life Sciences Corp.","BK4139":"生物科技"},"translate_title":"Anavex Life Sciences Corp. stock plunges 5.10% to $10.75 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVXL":1},"content_text":"北京时间2025年01月16日22时53分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.10%。截至发稿，该股报10.75美元/股，成交量18.9571万股，换手率0.22%，振幅5.83%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-43.00百万美元，每股收益-0.52美元，毛利0.00美元，市盈率-20.72倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，Channel Therapeutics Corporation、Cardio Diagnostics Holdings Inc C/Wts (01/12/2026) To Pur Com、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 (To Pur Ord)涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1542.32%、356.04%、227.55%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 (To Pur Com)、Aditxt, Inc.、Channel Therapeutics Corporation，振幅分别为131.33%、61.60%、47.24%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。公司分析临床研究中的基因组数据以识别进一步用于临床实验分析的生物标志物。公司专注于开发治疗阿尔茨海默病、帕金森病、精神分裂症、神经发育、神经退行性和罕见疾病，包括雷特综合症以及其他中枢神经系统（CNS）疾病。公司处于不同开发阶段的各种治疗候选药物包括Anavex 2-73（Blacamesine）、Anavex 3-71（AF710B）、Anavex 1-41和Anavex 1066。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2503156539","isCrawlerRequest":true}

Anavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元

精彩评论

Anavex Life Sciences Corp.盘中异动股价大跌5.10%报10.75美元